Dr. Cambi is a Board Certified Neurologist and a clinical investigator.  Her clinical practice is focused on Movement Disorders and Neurogenetics.  She has conducted several clinical trials on disease modifying agents for Parkinson Disease and has been a member of consortia on gene studies in Movement disorders and rare neurological diseases.  Her laboratory based research program has focused on several aspects of oligodendrocyte cell biology and myelination, ranging from transcriptional and post-transcriptional regulation of myelin gene expression and the impact of clinically relevant mutations on cell biology and myelin/axon biology in genetically modified mouse models.  A main focus of her current research is to investigate how oligodendrocyte and myelin contribute to recovery and repair from traumatic injuries and neurodegeneration.  Current studies are focused on the role of FUS, a DNA/RNA binding protein involved in transcriptional and post-transcriptional control of gene expression, in regulating myelination in development and in brain computer interface device performance in collaboration with Dr. Kozai. (Department of Bioengineering)